CurrOpinHematol 21:215223 Patel AP, Naik MR, Shah NM, Sharma N, Parmar P (2012) Prevalence of common hemoglobinopathies in Gujarat: an analysis of a large population screening programme
Shen X, Li H, Zhang B et al (2025) Tau-targeted therapeutic strategies: mechanistic targets, clinical pipelines, and analysis of failures
doi:10.1177/0748233709348393 Islam, M.T., Mishra, S.K., Tripathi, S., de Alencar, M.V.O.B., e Sousa, J.M.d.C., Rolim, H.M.L., de Medeiros, M.d.G.F., Ferreira, P.M.P., Rouf, R., Uddin, S.J., Mubarak, M.S
Development of interventions targeting amyloid beta plaques and tau protein tangles also have not been successful [8, 9], and the number of phase 3 trials focused on amyloid intervention has decreased since 2019 [10]
The CIBERER is an initiative from the Instituto de Salud Carlos III